Imstem Biotechnology, Inc
Advertisement
ImStem Biotechnology, Inc. is a biopharmaceutical company based in Farmington, Connecticut, focused on pioneering stem cell technology to develop transformative medicines for patients suffering from autoimmune diseases, degenerative conditions, and rare diseases. Since its incorporation in 2012, the company has aimed to enhance treatment outcomes and improve the quality of life for patients through innovative therapies.
ImStem's proprietary T-MSC technology involves differentiating human embryonic stem cells into mesenchymal stem cells with high efficiency, consistency, and quality. Currently, the company is conducting a clinical trial for its investigational drug, IMS001, which utilizes T-MSC to treat multiple sclerosis patients.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
